InvestorsHub Logo

flipper44

01/16/22 1:53 PM

#435553 RE: exwannabe #435552

And what are the program’s “restrictions.” Could they provide snake oil?

highwayman4life

01/16/22 1:59 PM

#435556 RE: exwannabe #435552

Wrong again!!

I guess you know better than
https://brainstrust.org.uk/wp-content/uploads/2019/03/brainstrust-know-hows-immunotherapy-10.02.19-1.pdf
DCVax®-L can be accessed privately on a very limited compassionate-use basis under the Specials regulation in the UK


While we're at it...what did you say the capacity for Sawston was? I recall 4-6 patients per month, correct?

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-mhra-approval-of-license-for-gmp-manufacturing-at-sawston-uk-facility-301449083.html
The Company anticipates that Phase 1A alone will be able to manufacture DCVax-L products for 45-50 patients per month, or 450-500 patients per year